Literature DB >> 6329368

Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial.

H H Balfour, G W Sachs, P Welo, R C Gehrz, R L Simmons, J S Najarian.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6329368

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


× No keyword cloud information.
  6 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 2.  Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.

Authors:  Javier Bueno; Carmen Ramil; Michael Green
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice.

Authors:  Weijia Wang; Shannon L Taylor; Stacey A Leisenfelder; Robert Morton; Jennifer F Moffat; Sergey Smirnov; Hua Zhu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 4.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection.

Authors:  Megan M Crumpler; K Yeon Choi; Michael A McVoy; Mark R Schleiss
Journal:  Vaccine       Date:  2009-05-03       Impact factor: 3.641

Review 6.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.